OpenScience.ink

1 week ago • The international journal of lower extremity wounds

Links Between Diabetes Medicines That Target GLP-1 and Foot Problems in Diabetes Using Real-World Data and Genetic AnalysisAssessing the Association Between GLP-1 Receptor Agonists and Diabetic Foot Complications Using Real-World Pharmacovigilance Database and Mendelian Randomization.

Article

1 week ago • Annals of medicine and surgery (2012)

Sudden inflammation of the pancreas after semaglutide treatment: a case reportAcute pancreatitis following semaglutide therapy: a case report.

Case Reports

1 week ago • Heart & lung : the journal of critical care

Links between activating glucagon-like peptide-1 receptors, inflammation, and heart failure from genetic studiesGlucagon-like peptide-1 receptor activation, inflammation and heart failure: Insights from genetic analysis.

📖 Top 30% JournalArticle

1 week ago • The American journal of cardiology

Factors linked to serious heart problems around the time of weight-loss surgeryPredictors of Perioperative Major Adverse Cardiovascular Events After Bariatric Surgery.

📖 Top 20% JournalArticle

1 week ago • The British journal of cardiology

Using GLP-1 receptor activators in heart disease: guidance for heart doctorsGLP-1 receptor agonists in cardiovascular disease: a guide for cardiologists.

Article

1 week ago • Canadian journal of physiology and pharmacology

Heart and blood vessel effects of incretin receptor drugs beyond blood sugar controlCARDIOVASCULAR EFFECTS OF INCRETIN RECEPTOR AGONISTS: BEYOND GLYCEMIC CONTROL.

📖 Top 50% JournalArticle

1 week ago • BMC medicine

Use and uncertainties of GLP-1 and SGLT-2 treatments after pregnancy in women who had gestational diabetesPostpartum GLP-1 receptor agonists and SGLT-2 therapies in women with prior gestational diabetes: current evidence and uncertainties.

🥉 Top 5% JournalArticle

1 week ago • Current obesity reports

Changes in Fat Tissue After Incretin Treatments and Weight-Loss Surgery Beyond Just Losing WeightAdipose Tissue Remodeling Beyond Weight Loss: New Insights Into Incretin-Based Therapies and Bariatric Surgery.

🥉 Top 5% JournalArticle

1 week ago • Clinical science (London, England : 1979)

How the gut detects fat and triggers hormone releaseHow lipid ingestion is sensed: the mechanisms underlying intestinal hormone secretion.

Article

1 week ago • Nature reviews. Gastroenterology & hepatology

Expert advice on managing heart and liver health together in metabolic fatty liver diseaseHeart-liver co-management in MASLD: expert perspectives and recommendations from a multidisciplinary cardiometabolic framework.

🥇 Top 1% JournalArticle

1 week ago • American journal of physiology. Regulatory, integrative and comparative physiology

Intermittent Cold Exposure Raises Energy Use but Does Not Boost Weight Loss from Tirzepatide in Obese MiceIncreased Energy Expenditure through Intermittent Cold Exposure Does Not Enhance Tirzepatide Induced Weight-loss in Obese Mice.

Article

1 week ago • Drug design, development and therapy

Key Experimental Treatments and Missing Knowledge in Fat-Related Liver InflammationKey Experimental Therapeutics and Knowledge Gaps in Metabolic Dysfunction-Associated Steatohepatitis (MASH).

📖 Top 20% JournalArticle

1 week ago • Intestinal research

Comparing tirzepatide and GLP-1 drugs in patients with inflammatory bowel diseaseComparative outcomes for tirzepatide versus glucagon-like peptide-1 receptor agonists in patients with inflammatory bowel disease: a national propensity matched study.

📖 Top 20% JournalArticle

1 week ago • Frontiers in endocrinology

Electroacupuncture may allow lower semaglutide doses in type 2 diabetes by increasing drug levels and reducing insulin cell deathElectroacupuncture enables semaglutide dose sparing in type 2 diabetes by boosting drug concentration and suppressing β-cell apoptosis.

🎖️ Top 10% JournalArticle

1 week ago • Maturitas

Possible interaction between tirzepatide and oral hormone treatments in women’s health and menopause careTirzepatide and oral progestogens: A hypothesis-generating review of a biologically plausible pharmacokinetic interaction in gynaecologic disease control and menopausal hormone therapy.

📖 Top 20% JournalArticle

1 week ago • Diabetes & metabolism journal

Addressing Muscle Loss Risks in Treatments That Lower Blood SugarBeyond Fat Loss: Addressing the Sarcopenia Challenge of Incretin-Based Therapies.

Article

1 week ago • Journal of Alzheimer's disease : JAD

GLP-1 receptor treatment in Alzheimer's disease after EVOKE: moving from one idea to targeted approachesGLP-1 receptor agonism in Alzheimer's disease after EVOKE: From single hypothesis to stratified program.

📖 Top 20% JournalArticle

1 week ago • Aesthetic plastic surgery

Anesthetic Safety and Surgery Results in Patients Taking GLP-1 Medicines During Tummy Tuck SurgeryAnesthetic Safety and Perioperative Outcomes in GLP-1 Receptor Agonist-Treated Patients Undergoing Lipoabdominoplasty.

📖 Top 20% JournalArticle

1 week ago • Revue medicale suisse

Blood pressure effects of strong GLP-1 and GIP hormone-like drugs[Blood pressure effects of potent GLP-1 and GIP analogues].

English Abstract

1 week ago • Frontiers in endocrinology

Effects of incretin receptor drugs in patients after weight-loss surgery: a systematic review and meta-analysisUse of incretin receptor agonists in patients submitted to metabolic bariatric surgery - a systematic review and meta-analysis.

🎖️ Top 10% JournalSystematic Review

1 week ago • Endocrine reviews

Current knowledge, missing information, and future chances in obesity research with new medicinesObesity science, research gaps, and opportunities in the new era of obesity medicines: an Endocrine Society scientific statement.

🥇 Top 1% JournalArticle

1 week ago • Gastroenterology & hepatology

Use of Glucagon-Like Peptide-1 Receptor Agonists Before and After Liver TransplantGlucagon-Like Peptide-1 Receptor Agonist Use Before and After Liver Transplant.

📖 Top 20% JournalArticle

1 week ago • Frontiers in stroke

Using SGLT2 inhibitors and incretin-based drugs for heart and metabolism health after strokeCardiometabolic drugs after stroke: time to embrace SGLT2 inhibitors and incretin-based therapies?

Article

1 week ago • Digestion

Semaglutide and Tirzepatide for Treating Fatty Liver Disease with Inflammation: Current Options, Future Developments, and GapsSemaglutide and Tirzepatide for the treatment of MASH: What Works, What's Coming, and What's Missing.

📖 Top 20% JournalArticle

1 week ago • Journal of the American Heart Association

Tirzepatide and the risk of irregular heartbeat in adults with overweight or obesity: an updated analysis of clinical trialsTirzepatide and the Incidence of Atrial Fibrillation in Adults With Overweight or Obesity: An Updated Meta-Analysis of Randomized Controlled Trials.

🥉 Top 5% JournalArticle

1 week ago • Diabetes, obesity & metabolism

Study Plan and Starting Data for Using GLP-1 Drugs After Weight-Loss SurgeryGLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Trial: Rationale, Design and Baseline Characteristics.

Article

1 week ago • Pharmacology & therapeutics

Targeting long-term inflammation caused by cell death to treat fatty liver disease linked to metabolism problemsCell death-induced chronic inflammation as a therapeutic target for metabolic dysfunction-associated steatohepatitis.

Article

1 week ago • Frontiers in endocrinology

Tirzepatide and the risk of asthma attacks in people with type 2 diabetesTirzepatide and the risk of asthma exacerbations in patients with type 2 diabetes.

🎖️ Top 10% JournalArticle

1 week ago • Diabetes, obesity & metabolism

A Twice-Monthly GLP-1 Receptor Activator with Drug-Free Breaks for Better Effectiveness, Receptor Balance, and Gut ToleranceA Biweekly GLP-1R Agonist Designed With Drug-Free Intervals for Enhanced Efficacy, Receptor Homeostasis and Gastrointestinal Tolerability.

Article

1 week ago • PloS one

Effects of GLP-1 receptor drugs on patients with precancerous pancreatic cysts: Study plan for a multi-center patient groupImpact of GLP-1 receptor agonists on patients with intraductal papillary mucinous neoplasms: Study protocol for a multicentric cohort study.

📖 Top 30% JournalMulticenter Study

← prevpage 5 of 14next →

Latest GLP-1 Therapies Research Papers